GR76992B - - Google Patents
Info
- Publication number
- GR76992B GR76992B GR69416A GR820169416A GR76992B GR 76992 B GR76992 B GR 76992B GR 69416 A GR69416 A GR 69416A GR 820169416 A GR820169416 A GR 820169416A GR 76992 B GR76992 B GR 76992B
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8129937 | 1981-10-03 | ||
| GB8208988 | 1982-03-26 | ||
| GB08224871A GB2108510B (en) | 1981-10-03 | 1982-09-01 | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR76992B true GR76992B (US07122547-20061017-C00273.png) | 1984-09-04 |
Family
ID=27261323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR69416A GR76992B (US07122547-20061017-C00273.png) | 1981-10-03 | 1982-10-01 |
Country Status (19)
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
| DE3220116A1 (de) | 1982-05-28 | 1983-12-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung |
| NZ205924A (en) * | 1982-10-11 | 1987-07-31 | Nat Biolog Standards Board | Synthetic polypeptide: fragment of structural capsid protein; vaccine; method for diagnosis |
| IE56509B1 (en) * | 1982-11-04 | 1991-08-28 | Univ California | Methods for oncogenic detection |
| JPS60118196A (ja) * | 1983-11-30 | 1985-06-25 | Takeda Chem Ind Ltd | インタ−フェロンの製造法 |
| JPS6156199A (ja) * | 1984-08-27 | 1986-03-20 | Shionogi & Co Ltd | 新規ヒトインタ−フエロンα類 |
| EP0194006B1 (en) * | 1985-02-01 | 1992-04-29 | Imperial Chemical Industries Plc | Analogous interferon polypeptides, process for their preparation and pharmaceutical compositions containing them |
| GB8508685D0 (en) * | 1985-04-03 | 1985-05-09 | Minor P D | Peptides |
| EP0200417B1 (en) * | 1985-04-30 | 1992-10-21 | Takeda Chemical Industries, Ltd. | Production of protein |
| ATE78262T1 (de) * | 1985-06-11 | 1992-08-15 | Ciba Geigy Ag | Hybrid-interferone. |
| ATE125304T1 (de) | 1986-04-15 | 1995-08-15 | Ciba Geigy Ag | Monoklonale antikörper gegen interferon- induziertes humanes protein in gereignigter form, und diese antikörper enthaltende testsätze. |
| TW218846B (US07122547-20061017-C00273.png) * | 1992-04-07 | 1994-01-11 | Ciba Geigy | |
| US5733733A (en) * | 1992-08-04 | 1998-03-31 | Replicon, Inc. | Methods for the isothermal amplification of nucleic acid molecules |
| US6261808B1 (en) | 1992-08-04 | 2001-07-17 | Replicon, Inc. | Amplification of nucleic acid molecules via circular replicons |
| US5834202A (en) | 1992-08-04 | 1998-11-10 | Replicon, Inc. | Methods for the isothermal amplification of nucleic acid molecules |
| WO1994003624A1 (en) * | 1992-08-04 | 1994-02-17 | Auerbach Jeffrey I | Methods for the isothermal amplification of nucleic acid molecules |
| US20020102236A1 (en) * | 1994-12-08 | 2002-08-01 | Taylor Peter William | Liposomal interferon hybrid compositions |
| EP0801682B1 (en) | 1995-02-09 | 2001-10-24 | Novartis AG | Process for the production of proteins |
| US6087102A (en) * | 1998-01-07 | 2000-07-11 | Clontech Laboratories, Inc. | Polymeric arrays and methods for their use in binding assays |
| US6685933B1 (en) * | 1998-07-28 | 2004-02-03 | The United States Of America As Represented By The Department Of Health And Human Services | Interferon α hybrids |
| DE19919149A1 (de) * | 1999-04-27 | 2000-11-16 | Wieser Raimund J | Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere |
| WO2002036627A2 (en) * | 2000-11-03 | 2002-05-10 | Pbl Biomedical Laboratories | Interferons, uses and compositions related thereto |
| WO2002088161A1 (en) * | 2001-05-02 | 2002-11-07 | Pepgen Corporation | Method for expression of human interferon alpha 1 in pichia pa storis |
| FR2825716B1 (fr) | 2001-06-11 | 2004-09-24 | Genodyssee | Nouveaux polynucleotides et polypeptides de l'ifn alpha 7 |
| DE602005026854D1 (de) * | 2004-12-20 | 2011-04-21 | Cadila Healthcare Ltd | Verfahren zur herstellung von hohen niveaus von interferon-beta |
| CN110172309B (zh) | 2016-11-21 | 2022-08-16 | 日东电工株式会社 | 粘合片 |
| KR102055078B1 (ko) | 2016-11-21 | 2019-12-11 | 닛토덴코 가부시키가이샤 | 점착 시트 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA796175B (en) * | 1978-11-24 | 1980-11-26 | Hoffmann La Roche | Purified proteins and process therefor |
| AU538665B2 (en) * | 1979-10-30 | 1984-08-23 | Juridical Foundation, Japanese Foundation For Cancer Research | Human interferon dna |
| CY1346A (en) * | 1980-01-08 | 1987-01-16 | Biogen Nv | Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides |
| DE3005897A1 (de) * | 1980-02-16 | 1981-09-03 | Hoechst Ag, 6000 Frankfurt | Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus |
| KR860001471B1 (ko) * | 1980-04-03 | 1986-09-26 | 비오겐 엔. 브이 | 인체의 섬유아세포 인터페론(IFN-β)폴리펩티드의 제조방법 |
| EP0042246B1 (en) * | 1980-06-12 | 1987-03-18 | The Cancer Institute Of Japanese Foundation For Cancer Research | Plasmid |
| ES8302778A1 (es) * | 1980-11-10 | 1983-02-01 | Genentech Inc | Un procedimiento para producir un polipeptido antiviral. |
| GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
-
1982
- 1982-09-01 GB GB08224871A patent/GB2108510B/en not_active Expired
- 1982-09-30 KR KR8204446A patent/KR920007665B1/ko active
- 1982-09-30 IL IL66920A patent/IL66920A0/xx unknown
- 1982-10-01 DE DE8282109094T patent/DE3280174D1/de not_active Expired - Lifetime
- 1982-10-01 NO NO823314A patent/NO166494C/no unknown
- 1982-10-01 DK DK437382A patent/DK170714B1/da not_active IP Right Cessation
- 1982-10-01 GR GR69416A patent/GR76992B/el unknown
- 1982-10-01 PT PT75643A patent/PT75643B/pt not_active IP Right Cessation
- 1982-10-01 AU AU88958/82A patent/AU561104B2/en not_active Ceased
- 1982-10-01 DD DD82243742A patent/DD204266A5/de not_active IP Right Cessation
- 1982-10-01 NZ NZ202058A patent/NZ202058A/en unknown
- 1982-10-01 HU HU823164A patent/HU197047B/hu not_active IP Right Cessation
- 1982-10-01 EP EP82109094A patent/EP0076489B1/de not_active Expired - Lifetime
- 1982-10-01 PH PH27947A patent/PH21524A/en unknown
- 1982-10-01 ES ES516154A patent/ES516154A0/es active Granted
- 1982-10-01 FI FI823356A patent/FI80719C/fi not_active IP Right Cessation
- 1982-10-01 IE IE2385/82A patent/IE54051B1/en not_active IP Right Cessation
- 1982-10-04 JP JP57174426A patent/JPH06104066B2/ja not_active Expired - Lifetime
-
1983
- 1983-12-16 ES ES528141A patent/ES8601237A1/es not_active Expired
-
1985
- 1985-06-26 PH PH32461A patent/PH23119A/en unknown
-
1989
- 1989-03-07 US US07/320,185 patent/US5089400A/en not_active Expired - Fee Related
-
1994
- 1994-07-05 JP JP6153677A patent/JP2612149B2/ja not_active Expired - Lifetime
